All Stories

  1. Circulating cell-free DNA and NETosis-related biomarkers in schizophrenia: association with clinical features and treatment

    Article • The World Journal of Biological Psychiatry, September 2026, Taylor & Francis

    Svetlana A Ivanova

  2. Matrix metalloproteinases and vascular endothelial growth factor in the acute phase of ischemic stroke: correlation with pathogenetic subtypes and clinical outcomes

    Article • S S Korsakov Journal of Neurology and Psychiatry, September 2026, Media Sphere Publishing Group

    Svetlana A Ivanova

  3. Network analysis of psychopathological symptoms in patients with schizophrenia as a model for studying the clinical presentation

    Article • S S Korsakov Journal of Neurology and Psychiatry, August 2026, Media Sphere Publishing Group

    Svetlana A Ivanova

  4. The fundamental contribution of the Mental Health Research Institute to the establishment of academic foundations and traditions of a scientific approach in Siberia and the Far East, and to the coordination of research activities in psychiatry and Narc...

    Article • Сибирский вестник психиатрии и наркологии, July 2026, Mental Health Research Institute

    Svetlana A Ivanova, Prof Nikolay A. Bokhan

  5. The content of immunoinflammation markers in peripheral blood mononuclears in alcohol dependence and affective disorders

    Article • Psychiatry (Moscow) (Psikhiatriya), June 2026, Medical Informational Agency Publishers

    Svetlana A Ivanova, Prof Nikolay A. Bokhan

  6. A Population Frequency Study of TCF4 Gene Polymorphisms Associated with Schizophrenia Based on Genomic Databases

    Article • Psychiatry International, May 2026, MDPI AG

    Svetlana A Ivanova

  7. Prognostic value of atherogenicity indices in schizophrenia patients with metabolic syndrome

    Article • S S Korsakov Journal of Neurology and Psychiatry, April 2026, Media Sphere Publishing Group

    Svetlana A Ivanova

  8. Serum NOS1AP concentration: association with clinical schizophrenia polymorphism and metabolic syndrome

    Article • S S Korsakov Journal of Neurology and Psychiatry, April 2026, Media Sphere Publishing Group

    Svetlana A Ivanova

  9. Heterogeneity of VEGF dynamics in the acute period of ischemic stroke: association with disease severity and short-term outcomes

    Article • Bulletin of Siberian Medicine, April 2026, Siberian State Medical University

    Svetlana A Ivanova

  10. Polymorphic variants of genes of BDNF-mediated protein kinase signaling pathways in patients with schizophrenia: association analysis and functional annotation of genes

    Article • Сибирский вестник психиатрии и наркологии, March 2026, Mental Health Research Institute

    Svetlana A Ivanova

  11. Effect of polymorphic variants of genes of neurotrophic factors on the disease severity and the anxiety level in patients with affective disorders and comorbid alcohol dependence

    Article • S S Korsakov Journal of Neurology and Psychiatry, February 2026, Media Sphere Publishing Group

    Svetlana A Ivanova

  12. Glutathione antioxidant pathways in patients with schizophrenia: relationship with metabolic syndrome

    Article • The World Journal of Biological Psychiatry, January 2026, Taylor & Francis

    Svetlana A Ivanova, Prof Nikolay A. Bokhan

  13. Polymorphic variants of proinflammatory cytokine genes in affective disorders and in cases of comorbidity with alcohol addiction

    Article • Russian Journal of Immunology, January 2026, Russian Society of Immunology

    Svetlana A Ivanova, Prof Nikolay A. Bokhan

  14. Constitutional and biological predictors of the risk of suicidal behavior in mental disorders

    Article • Bulletin of Siberian Medicine, January 2026, Siberian State Medical University

    Svetlana A Ivanova

  15. Neurocognitive deficits in schizophrenia and polymorphic variants of protein kinase signaling pathway genes: search for associations

    Article • Bulletin of Siberian Medicine, January 2026, Siberian State Medical University

    Svetlana A Ivanova

  16. Immunobiological markers of the effectiveness of antipsychotic therapy in patients with schizophrenia

    Article • Сибирский вестник психиатрии и наркологии, January 2026, Mental Health Research Institute

    Svetlana A Ivanova, Valentina Nikitina

  17. Polymorphism of neurotrophin genes and aggressive behavior in patients with affective disorders

    Article • Сибирский вестник психиатрии и наркологии, January 2026, Mental Health Research Institute

    Svetlana A Ivanova

  18. Assessment of the change over time of serum matrix metalloproteinases and vascular endothelial growth factor in the acute period of ischemic stroke

    Article • S S Korsakov Journal of Neurology and Psychiatry, December 2025, Media Sphere Publishing Group

    Svetlana A Ivanova

  19. Protein Kinase Expression of the AKT/mTOR Signaling Pathway in Peripheral Mononuclear Cells of Schizophrenia Patients: A Pilot Study

    Article • NeuroSci, November 2025, MDPI AG

    Svetlana A Ivanova, Prof Nikolay A. Bokhan

  20. Myeloperoxidase, Cathepsin D, and Plasminogen Activation Inhibitor Type 1 as Potential Biomarkers of Schizophrenia (pilot study)

    Article • V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY, November 2025, V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology

    Svetlana A Ivanova, Prof Nikolay A. Bokhan

  21. Positive and Negative Symptoms of Schizophrenia and Polymorphic Variants of the TCF4 Gene: Pilot Associative Study

    Article • International Journal of Molecular Sciences, October 2025, MDPI AG

    Svetlana A Ivanova, Prof Nikolay A. Bokhan

  22. Регуляторный потенциал полиморфных вариантов генов BDNF-опосредованных протеинкиназных сигнальных путей, ассоциированных с шизофренией

    Article • Сибирский вестник психиатрии и наркологии, October 2025, Mental Health Research Institute

    Svetlana A Ivanova

  23. Polymorphic Variants of Neurotrophic Factor Genes in Affective Disorders: Pilot Study

    Article • International Journal of Molecular Sciences, August 2025, MDPI AG

    Svetlana A Ivanova, Prof Nikolay A. Bokhan

  24. Neuroinflammation in Schizophrenia: An Overview of Evidence and Implications for Pathophysiology

    Article • Journal of Integrative Neuroscience, July 2025, IMR Press

    Svetlana A Ivanova, Evgeny Ermakov

  25. Polymorphic variant of NQO1 rs1800566 and antipsychotic-induced metabolic disorders in patients with schizophrenia

    Article • Bulletin of Siberian Medicine, July 2025, Siberian State Medical University

    Svetlana A Ivanova

  26. Academic Psychiatric School in Siberia: History of Formation and Horizons of Development. Interview with an Academician of RAS Nikolay A. Bokhan

    Article • Psychiatry (Moscow) (Psikhiatriya), June 2025, Medical Informational Agency Publishers

    Svetlana A Ivanova, Prof Nikolay A. Bokhan, Svetlana Vladimirova

  27. The Effect of Metabolic Syndrome and its Individual Components on the Duration of the QTc Interval in Different Gene Carriers of the Nitric Oxide Synthase 1 Adapter Protein Gene in Patients with Schizophrenia

    Article • Psychiatry (Moscow) (Psikhiatriya), June 2025, Medical Informational Agency Publishers

    Svetlana A Ivanova

  28. The Role of GST Gene Polymorphic Variants in Antipsychotic-Induced Metabolic Disorders in Schizophrenia: A Pilot Study

    Article • Pharmaceuticals, June 2025, MDPI AG

    Svetlana A Ivanova, Prof Nikolay A. Bokhan

  29. Neuroinflammatory and neurodegenerative aspects of Parkinson’s disease

    Article • S S Korsakov Journal of Neurology and Psychiatry, April 2025, Media Sphere Publishing Group

    Svetlana A Ivanova

  30. The association of NOS1AP gene polymorphisms with the duration of the QT interval in patients with schizophrenia receiving antipsychotic therapy

    Article • S S Korsakov Journal of Neurology and Psychiatry, February 2025, Media Sphere Publishing Group

    Svetlana A Ivanova

  31. Прогнозирование эффективности фармакотерапии у больных депрессивными расстройствами на основе генетических показателей

    Article • Сибирский вестник психиатрии и наркологии, October 2024, Mental Health Research Institute

    Svetlana A Ivanova

  32. Blood Growth Factor Levels in Patients with Systemic Lupus Erythematosus: High Neuregulin-1 is Associated with Comorbid Cardiovascular Pathology

    Article • Life, October 2024, MDPI AG

    Svetlana A Ivanova, Evgeny Ermakov

  33. Взаимосвязь тромбоцитарных факторов роста с клиническими и клинико-динамическими характеристиками у пациентов с аффективными расстройствами

    Article • Сибирский вестник психиатрии и наркологии, July 2024, Mental Health Research Institute

    Svetlana A Ivanova, Prof Nikolay A. Bokhan, Valentina Nikitina

  34. Comparative analysis of EEG in patients with schizophrenia receiving various atypical antipsychotics

    Article • Bulletin of Siberian Medicine, April 2024, Siberian State Medical University

    Svetlana A Ivanova

  35. Ассоциативный анализ гаплотипов и регуляторный потенциал генов серотониновых рецепторов у больных шизофренией с тардивной дискинезией

    Article • Сибирский вестник психиатрии и наркологии, March 2024, Mental Health Research Institute

    Svetlana A Ivanova

  36. NOS1AP Gene Variants and Their Role in Metabolic Syndrome: A Study of Patients with Schizophrenia

    Article • Biomedicines, March 2024, MDPI AG

    Svetlana A Ivanova, Prof Nikolay A. Bokhan

  37. Untargeted Plasma Metabolomic Profiling in Patients with Depressive Disorders: A Preliminary Study

    Article • Metabolites, February 2024, MDPI AG

    Svetlana A Ivanova, Alexander Chernonosov, Prof Nikolay A. Bokhan

  38. Associations between components of metabolic syndrome and cognitive impairment in patients with schizophrenia

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2024, Media Sphere Publishing Group

    Svetlana A Ivanova, Prof Nikolay A. Bokhan

  39. Associations of serum neuromarkers with clinical features of Parkinson’s disease

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2024, Media Sphere Publishing Group

    Svetlana A Ivanova

  40. Serum neurofilament light chains in assessing the course of multiple sclerosis

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2024, Media Sphere Publishing Group

    Svetlana A Ivanova

  41. The relationship between the rs6265 polymorphism of the BDNF gene and the level of serum neurotrophic factor in patients with Parkinson’s disease

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2024, Media Sphere Publishing Group

    Svetlana A Ivanova

  42. Association of inflammation and chronic fatigue syndrome in patients with Parkinson’s disease

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2024, Media Sphere Publishing Group

    Svetlana A Ivanova

  43. Growth factors PDGF-AA, PDGF-BB and BDNF as potential differentiating biomarkers of unipolar and bipolar depression

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2024, Media Sphere Publishing Group

    Svetlana A Ivanova, Prof Nikolay A. Bokhan

  44. A pilot study of associations of markers of glial and neuronal degeneration with executive functions in alcohol use disorders

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2024, Media Sphere Publishing Group

    Svetlana A Ivanova, Prof Nikolay A. Bokhan

  45. Serum neurofilaments light chain as a diagnostic marker of multiple sclerosis

    Article • Russian neurological Journal, November 2023, Medical Informational Agency Publishers

    Svetlana A Ivanova

  46. Differential Expression of Proteins Associated with Bipolar Disorder as Identified Using the PeptideShaker Software

    Article • International Journal of Molecular Sciences, October 2023, MDPI AG

    Svetlana A Ivanova

  47. Relationship of Neurospecific Serum Proteins with Clinical Features in Depressive Episode and Recurrent Depressive Disorder

    Article • Psychiatry (Moscow) (Psikhiatriya), September 2023, Medical Informational Agency Publishers

    Svetlana A Ivanova, Prof Nikolay A. Bokhan

  48. Serum Levels of S100B Protein and Myelin Basic Protein as a Potential Biomarkers of Recurrent Depressive Disorders

    Article • Journal of Personalized Medicine, September 2023, MDPI AG

    Svetlana A Ivanova, Prof Nikolay A. Bokhan

  49. Association of Single Nucleotide Polymorphisms of Cytokine Genes with Depression, Schizophrenia and Bipolar Disorder

    Article • Genes, July 2023, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova, Evgeny Ermakov

  50. Building Predictive Models for Schizophrenia Diagnosis with Peripheral Inflammatory Biomarkers

    Article • Biomedicines, July 2023, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova, Evgeny Ermakov

  51. EEG Frontal Asymmetry in Unipolar and Bipolar Depression

    Article • Psychiatry (Moscow) (Psikhiatriya), June 2023, Medical Informational Agency Publishers

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  52. Association of Peripheral Inflammatory Biomarkers and Growth Factors Levels with Sex, Therapy and Other Clinical Factors in Schizophrenia and Patient Stratification Based on These Data

    Article • Brain Sciences, May 2023, MDPI AG

    Svetlana A Ivanova, Evgeny Ermakov

  53. Роль полиморфизма генов дофаминовой и глутаматной систем в клинической гетерогенности шизофрении и развитии антипсихотик-индуцированных побочных эффектов

    Article • Сибирский вестник психиатрии и наркологии, April 2023, Mental Health Research Institute

    Svetlana A Ivanova

  54. The Influence of Antipsychotic Treatment on the Activity of Abzymes Targeting Myelin and Levels of Inflammation Markers in Patients with Schizophrenia

    Article • Biomedicines, April 2023, MDPI AG

    Svetlana A Ivanova

  55. Serum Growth Factors in Schizophrenia Patients

    Article • Current Issues in Molecular Biology, April 2023, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  56. In vitro effect of serum IgGs with oxidoreductase activities of schizophrenic patients on apoptosis level

    Article • Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery), March 2023, PANORAMA Publishing House

    Svetlana A Ivanova

  57. Cell Adhesion Molecules in Schizophrenia Patients with Metabolic Syndrome

    Article • Metabolites, March 2023, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  58. The Role of Glutamatergic Gene Polymorphisms in the Clinical Phenotypes of Schizophrenia

    Article • Genes, February 2023, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  59. Chemokine Dysregulation and Neuroinflammation in Schizophrenia: A Systematic Review

    Article • International Journal of Molecular Sciences, January 2023, MDPI AG

    Svetlana A Ivanova, Evgeny Ermakov

  60. Coherence of the electroencephalogram and peripheral markers of nerve tissue damage in depressive disorders

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2023, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  61. BDNF gene RS6265 polymorphism in patients with multiple sclerosis of Tomsk region

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2023, Media Sphere Publishing Group

    Svetlana A Ivanova

  62. Cytokines as Potential Biomarkers of Clinical Characteristics of Schizophrenia

    Article • Life, November 2022, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  63. Multiplex Analysis of Serum Cytokine Profiles in Systemic Lupus Erythematosus and Multiple Sclerosis

    Article • International Journal of Molecular Sciences, November 2022, MDPI AG

    Svetlana A Ivanova, Evgeny Ermakov

  64. Executive dysfunction in affective disorders: differences in bipolar affective disorder and depressive episode

    Article • Bulletin of Siberian Medicine, October 2022, Siberian State Medical University

    Svetlana A Ivanova

  65. Metabolic Hormones in Schizophrenia Patients with Antipsychotic-Induced Metabolic Syndrome

    Article • Journal of Personalized Medicine, October 2022, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  66. Levels of Acylcarnitines and Branched-Chain Amino Acids in Antipsychotic-Treated Patients with Paranoid Schizophrenia with Metabolic Syndrome

    Article • Metabolites, September 2022, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova, Alexander Chernonosov

  67. Immunoglobulins G of Patients with Schizophrenia Protects from Superoxide: Pilot Results

    Article • Journal of Personalized Medicine, September 2022, MDPI AG

    Svetlana A Ivanova

  68. Cytokine level in patients with mood disorder, alcohol use disorder and their comorbidity

    Article • The World Journal of Biological Psychiatry, July 2022, Taylor & Francis

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  69. The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia

    Article • Genes, July 2022, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  70. Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein

    Article • International Journal of Molecular Sciences, July 2022, MDPI AG

    Svetlana A Ivanova

  71. Serum Cytokine Levels of Systemic Lupus Erythematosus Patients in the Presence of Concomitant Cardiovascular Diseases

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, July 2022, Bentham Science Publishers

    Svetlana A Ivanova, Evgeny Ermakov

  72. Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia

    Article • Diagnostics, June 2022, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  73. Circuits regulating pleasure and happiness – focus on potential biomarkers for circuitry including the habenuloid complex

    Article • Acta Neuropsychiatrica, May 2022, Cambridge University Press

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  74. Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome

    Article • Genes, May 2022, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  75. Возможные нейрофизиологические маркеры для дифференциальной диагностики биполярных и униполярных аффективных расстройств

    Article • Сибирский вестник психиатрии и наркологии, January 2022, Mental Health Research Institute

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  76. Оценка цитотоксических эффектов IgG, выделенных из сыворотки крови больных шизофренией

    Article • Сибирский вестник психиатрии и наркологии, January 2022, Mental Health Research Institute

    Svetlana A Ivanova

  77. Molecular genetic study of clinical and cognitive features of schizophrenia: No associations with genes SOD2, GSTO1, NQO1

    Article • Siberian Journal of Clinical and Experimental Medicine, January 2022, Cardiology Research Institute

    Svetlana A Ivanova

  78. Anhedonia as target symptom in personalized therapy of patients with mood disorders and alcohol use disorder comorbidity

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2022, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  79. Current methods for predicting therapeutic response in patients with depressive disorders

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2022, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  80. Correlations between clinical features of bipolar affective disorder and serum concentrations of ANKRD12 gene product, coagulation factor XIII, and cadherin 5

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2022, Media Sphere Publishing Group

    Svetlana A Ivanova

  81. Metabolic Syndrome in a Population of In-Patients with Schizophrenia in the Western Siberia

    Article • Psychiatry (Moscow) (Psikhiatriya), December 2021, Medical Informational Agency Publishers

    Svetlana A Ivanova

  82. A New Paradigm to Indicate Antidepressant Treatments

    Article • Pharmaceuticals, December 2021, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  83. Beta-Endorphin and Oxytocin in Patients with Alcohol Use Disorder and Comorbid Depression

    Article • Journal of Clinical Medicine, December 2021, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  84. Assessment of serum BDNF levels in complex rehabilitation of patients with ischemic stroke using traditional approaches to the restoration of motor functions

    Article • Bulletin of Siberian Medicine, October 2021, Siberian State Medical University

    Svetlana A Ivanova

  85. Association of PIP4K2A Polymorphisms with Alcohol Use Disorder

    Article • Genes, October 2021, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  86. Влияние органических солей лития на содержание белков Akt/mTOR-сигнального пути в мононуклеарах периферической крови больных биполярным аффективным расстройством

    Article • Сибирский вестник психиатрии и наркологии, October 2021, Mental Health Research Institute

    Svetlana A Ivanova

  87. Study of Early Onset Schizophrenia: Associations of GRIN2A and GRIN2B Polymorphisms

    Article • Life, September 2021, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  88. Clinical Evaluation of Different Treatment Strategies for Motor Recovery in Poststroke Rehabilitation during the First 90 Days

    Article • Journal of Clinical Medicine, August 2021, MDPI AG

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  89. Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action

    Article • Journal of Personalized Medicine, July 2021, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  90. Global hypomyelination of the brain white and gray matter in schizophrenia: quantitative imaging using macromolecular proton fraction

    Article • Translational Psychiatry, June 2021, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  91. Electroencephalographic Markers of Depressive Disorders Resistance to Pharmacotherapy and Determination of a Possible Approach to Individual Prognosis of Therapy Effectiveness

    Article • Psychiatry (Moscow) (Psikhiatriya), June 2021, Medical Informational Agency Publishers

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  92. Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics

    Article • Pharmaceuticals, May 2021, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  93. Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia

    Article • Journal of Personalized Medicine, March 2021, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  94. Features of brain activity in alcohol dependence in the task of inhibitory control

    Article • Bulletin of Siberian Medicine, January 2021, Siberian State Medical University

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  95. Amino Acid and Acylcarnitine Levels in Chronic Patients with Schizophrenia: A Preliminary Study

    Article • Metabolites, January 2021, MDPI AG

    Prof Nikolay A. Bokhan, Svetlana A Ivanova, Alexander Chernonosov

  96. Cognitive impairment in patients after COVID-19

    Article • Yakut Medical Journal, January 2021, Yakutsk Scientific Center for Complex Medical Problems

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  97. Влияние когнитивных функций на уровень суицидального риска у больных шизофренией

    Article • Суицидология, December 2020, LLC M-Center

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  98. Using the quantitative EEG method in predicting the response to treatment of affective disorders

    Article • V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY, December 2020, V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  99. Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia

    Article • Metabolites, October 2020, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  100. Модель прогнозирования метаболического синдрома у больных параноидной шизофренией

    Article • Сибирский вестник психиатрии и наркологии, September 2020, Mental Health Research Institute

    Svetlana A Ivanova

  101. Cognitive Changes in Comorbidity Alcohol Dependence and Affective Disorders

    Article • Psychiatry (Moscow) (Psikhiatriya), September 2020, Medical Informational Agency Publishers

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  102. Glutamate Level’s in Blood Serum of Patients with Schisophrenic Spectrum and Bipolar Affective Disorder

    Article • Psychiatry (Moscow) (Psikhiatriya), September 2020, Medical Informational Agency Publishers

    Svetlana A Ivanova

  103. Body Fat Parameters, Glucose and Lipid Profiles, and Thyroid Hormone Levels in Schizophrenia Patients with or without Metabolic Syndrome

    Article • Diagnostics, September 2020, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova, Dr Olga Lobacheva

  104. Serum BDNF’s Role as a Biomarker for Motor Training in the Context of AR-Based Rehabilitation after Ischemic Stroke

    Article • Brain Sciences, September 2020, MDPI AG

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  105. Igg-Dependent Hydrolysis of Myelin Basic Protein of Patients with Different Courses of Schizophrenia

    Article • Journal of Immunology Research, August 2020, Hindawi Publishing Corporation

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  106. Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia

    Article • Human Psychopharmacology Clinical and Experimental, May 2020, Wiley

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  107. Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia

    Article • April 2020, Taylor & Francis

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  108. Therapeutic Drug Monitoring of Olanzapine and Cytochrome P450 Genotyping in Nonsmoking Subjects

    Article • Therapeutic Drug Monitoring, April 2020, Wolters Kluwer Health

    Svetlana A Ivanova

  109. Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients

    Article • Frontiers in Psychiatry, February 2020, Frontiers

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  110. IgG-Dependent Dismutation of Superoxide in Patients with Different Types of Multiple Sclerosis and Healthy Subjects

    Article • Oxidative Medicine and Cellular Longevity, February 2020, Hindawi Publishing Corporation

    Svetlana A Ivanova

  111. Amino acids and acylcarnitines as potential metabolomic markers of schizophrenia: new approaches to diagnostics and therapy

    Article • Bulletin of Siberian Medicine, January 2020, Siberian State Medical University

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  112. Clinical and laboratory assessment of the effectiveness of early rehabilitation of patients with stroke using assistive robotic tools

    Article • Bulletin of Siberian Medicine, January 2020, Siberian State Medical University

    Svetlana A Ivanova

  113. Relationship of cognitive disorders with clinical features of alcohol dependence

    Article • Yakut Medical Journal, January 2020, Yakutsk Scientific Center for Complex Medical Problems

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  114. Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression

    Article • Frontiers in Pharmacology, December 2019, Frontiers

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  115. Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: A prospective inception cohort study in treatment-free patients

    Article • Journal of Affective Disorders, December 2019, Elsevier

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  116. Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome

    Article • Frontiers in Psychiatry, November 2019, Frontiers

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  117. Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophrenia

    Article • Pharmacogenomics, November 2019, Future Medicine

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  118. Sexual differences in the clinical features of antipsychotic-induced hyperprolactinemia in patients with schizophrenia

    Article • Bulletin of Siberian Medicine, October 2019, Siberian State Medical University

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  119. Суицидальное поведение больных шизофренией с метаболическим синдромом

    Article • Суицидология, August 2019, LLC M-Center

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  120. Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia

    Article • Heliyon, July 2019, Elsevier

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  121. The difference in serum proteomes in schizophrenia and bipolar disorder

    Article • BMC Genomics, July 2019, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  122. Association of Polymorphic Variants of Brain-Derived Neurotrophic Factor Gene (Bdnf Rs6265) and Glutamate Transporter Gene of the Second Type (Slc1a2 Rs4354668) with the Course of Multiple Sclerosis in Patients Living in Tomsk Region

    Article • Annals of the Russian academy of medical sciences, April 2019, Paediatrician Publishers LLC

    Svetlana A Ivanova

  123. A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia

    Article • BMC Medical Genetics, April 2019, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  124. Consider Role of Glutamatergic Habenula-projecting Globus Pallidus in OCD

    Article • Pharmacopsychiatry, February 2019, Thieme Publishing Group

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  125. Opening up new horizons for psychiatric genetics in the Russian Federation: moving toward a national consortium

    Article • Molecular Psychiatry, January 2019, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  126. Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors

    Article • The World Journal of Biological Psychiatry, January 2019, Taylor & Francis

    Svetlana A Ivanova, Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan

  127. SIRT1 Allele Frequencies in Depressed Patients of European Descent in Russia

    Article • Frontiers in Genetics, January 2019, Frontiers

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  128. Disorders of spatial working memory in affective disorders with mild current depression and their neurophysiological correlates

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2019, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  129. No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic-induced tardive dyskinesia

    Article • Human Psychopharmacology Clinical and Experimental, January 2019, Wiley

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  130. Brain pathology in schizophrenia: association with clinical and constitutional factors

    Article • Yakut Medical Journal, January 2019, Yakutsk Scientific Center for Complex Medical Problems

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  131. NEUROPHYSIOLOGICAL FEATURES OF PATIENTS WITH DIFFERENT RATES OF ALCOHOL DEPENDENCE DEVELOPMENT

    Article • Вопросы наркологии, January 2019, Journal of Addiction Problems, V. Serbsky NMRCPN

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  132. Stress hormones in men whose professional activities are either office-based or of an extreme emergency nature

    Article • Yakut Medical Journal, January 2019, Yakutsk Scientific Center for Complex Medical Problems

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  133. Morphophenotypic predictor of the development of visceral obesity in patients with schizophrenia receiving antipsychotic therapy

    Article • Bulletin of Siberian Medicine, December 2018, Siberian State Medical University

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  134. Суицидальное поведение больных биполярным аффективным расстройством при коморбидных психических заболеваниях

    Article • Суицидология, November 2018, LLC M-Center

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  135. The evolutionary old forebrain as site of action to develop new psychotropic drugs

    Article • Journal of Psychopharmacology, September 2018, SAGE Publications

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  136. IgG antibodies from the sera of patients degrade myelin basic protein

    Article • Journal of Molecular Recognition, August 2018, Wiley

    Evgeny Ermakov, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  137. Polymorphisms of Catechol-O-Methyl Transferase (COMT) Gene in Vulnerability to Levodopa-Induced Dyskinesia

    Article • Journal of Pharmacy & Pharmaceutical Sciences, August 2018, University of Alberta Libraries

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  138. Remaining Need for In Vitro Test to Elucidate 5-Hydroxytryptamine 2C Receptor Functioning

    Article • Journal of Clinical Psychopharmacology, August 2018, Wolters Kluwer Health

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  139. The functional variant rs334558 of GSK3B is associated with remission in patients with depressive disorders

    Article • Pharmacogenomics and Personalized Medicine, July 2018, Dove Medical Press

    Prof. dr. Anton J Loonen, Svetlana A Ivanova, Anastasia Levchenko, Prof Nikolay A. Bokhan

  140. Parkinson's disease and polymorphisms of the glutamatergic system genes GRIN2A, SLC1A2, and GRIK4

    Article • Neurology neuropsychiatry Psychosomatics, June 2018, IMA Press, LLC

    Svetlana A Ivanova

  141. Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and metabolic syndrome in healthy subjects and schizophrenia patients

    Article • International Journal of Obesity, June 2018, Springer Science + Business Media

    Svetlana A Ivanova

  142. Blood-Derived RNA- and microRNA-Hydrolyzing IgG Antibodies in Schizophrenia Patients

    Article • Biochemistry (Moscow), May 2018, Pleiades Publishing Ltd

    Evgeny Ermakov, Svetlana A Ivanova

  143. Hydrolysis by catalytic IgGs of microRNA specific for patients with schizophrenia

    Article • IUBMB Life, January 2018, Wiley

    Evgeny Ermakov, Svetlana A Ivanova

  144. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Clozapine

    Article • The Journal of Clinical Psychiatry, December 2017, Physicians Postgraduate Press, Inc

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  145. Commentary on “A non-reward attractor theory of depression”: A proposal to include the habenula connection

    Article • Neuroscience & Biobehavioral Reviews, December 2017, Elsevier

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  146. How brain mechanism of feeling pleasure and happiness evolved during the last 560 million years.

    Article • CNS Spectrums, November 2017, Cambridge University Press

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  147. Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia

    Article • PLOS One, September 2017, PLOS

    Evgeny Ermakov, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  148. The role of the habenula in the transition from reward to misery in substance use and mood disorders

    Article • Neuroscience & Biobehavioral Reviews, September 2017, Elsevier

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  149. Circuits regulating pleasure and happiness: evolution and role in mental disorders

    Article • Acta Neuropsychiatrica, May 2017, Cambridge University Press

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  150. Neurohumoral markers that predict the efficiency of pharmacologic therapy of depressive disorders

    Article • Neurochemical Journal, April 2017, Pleiades Publishing Ltd

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  151. Prolactin gene polymorphism (− 1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics

    Article • Schizophrenia Research, April 2017, Elsevier

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  152. Association of Polymorphisms of Serotonin Transporter (5HTTLPR) and 5-HT2C Receptor Genes with Criminal Behavior in Russian Criminal Offenders

    Article • Neuropsychobiology, January 2017, Karger Publishers

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  153. Association of polymorphic variants of PIP5K2A and HTR2C genes with response to antidepressant therapy of patients with a current depressive episode

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2017, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  154. Association study of genetic markers of schizophrenia and its cognitive endophenotypes

    Article • Russian Journal of Genetics, January 2017, Pleiades Publishing Ltd

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  155. Indices of the antioxidant system and dopamine in blood plasma in the dynamics of microwave resonance therapy in patients with alcoholism

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2017, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  156. Circuits Regulating Pleasure and Happiness in Bipolar Disorder

    Article • Frontiers in Neural Circuits, January 2017, Frontiers

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  157. Circuits Regulating Pleasure and Happiness in Schizophrenia: The Neurobiological Mechanism of Delusions

    Article • December 2016, IntechOpen

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  158. Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations

    Article • SAGE Open Medicine, November 2016, SAGE Publications

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  159. Circuits Regulating Pleasure and Happiness: The Evolution of the Amygdalar-Hippocampal-Habenular Connectivity in Vertebrates

    Article • Frontiers in Neuroscience, November 2016, Frontiers

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  160. Circuits Regulating Pleasure and Happiness—Mechanisms of Depression

    Article • Frontiers in Human Neuroscience, November 2016, Frontiers

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  161. Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia

    Article • The World Journal of Biological Psychiatry, September 2016, Taylor & Francis

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  162. Circuits Regulating Pleasure and Happiness: A Focus on Addiction, Beyond the Ventral Striatum

    Article • July 2016, IntechOpen

    Svetlana A Ivanova

  163. CYP1A2 and CYP2D6 Gene Polymorphisms in Schizophrenic Patients with Neuroleptic Drug-Induced Side Effects

    Article • Bulletin of Experimental Biology and Medicine, March 2016, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  164. Circuits regulating pleasure and happiness in major depression

    Article • Medical Hypotheses, February 2016, Elsevier

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  165. Antioxidant and Immunotropic Properties of some Lithium Salts

    Article • Journal of Applied Biology & Biotechnology, January 2016, Journal of Applied Pharmaceutical Science

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  166. Use of Carnosine for Oxidative Stress Reduction in Different Pathologies

    Article • Oxidative Medicine and Cellular Longevity, January 2016, Hindawi Publishing Corporation

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  167. Antibodies to native and denatured DNA in the serum of patients with schizophrenia depending on the clinical features of the disease

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2016, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  168. The association of the DRD3 gene with Parkinson’s disease

    Article • S S Korsakov Journal of Neurology and Psychiatry, January 2016, Media Sphere Publishing Group

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  169. Levodopa-Induced Dyskinesia Is Related to Indirect Pathway Medium Spiny Neuron Excitotoxicity: A Hypothesis Based on an Unexpected Finding

    Article • Parkinson s Disease, January 2016, Hindawi Publishing Corporation

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  170. An association of AKT1 gene polymorphism with antidepressant treatment response

    Article • The World Journal of Biological Psychiatry, December 2015, Informa Healthcare

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  171. Serum Glutathione in Patients with Schizophrenia in Dynamics of Antipsychotic Therapy

    Article • Bulletin of Experimental Biology and Medicine, December 2015, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  172. Circuits regulating pleasure and happiness: the evolution of reward-seeking and misery-fleeing behavioral mechanisms in vertebrates

    Article • Frontiers in Neuroscience, October 2015, Frontiers

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  173. DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophrenia

    Article • Open Biology, September 2015, Royal Society Publishing

    Prof Nikolay A. Bokhan, Evgeny Ermakov, Svetlana A Ivanova

  174. Characteristics of membrane-bound pool of leukocyte lactate dehydrogenase in healthy men of different age

    Article • Human Physiology, July 2015, Pleiades Publishing Ltd

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  175. Serum Levels of Neurosteroids in Patients with Affective Disorders

    Article • Bulletin of Experimental Biology and Medicine, March 2015, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  176. Cytochrome P450 1A2 co-determines neuroleptic load and may diminish tardive dyskinesia by increased inducibility

    Article • The World Journal of Biological Psychiatry, January 2015, Taylor & Francis

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  177. Association Study Indicates a Protective Role of Phosphatidylinositol-4-Phosphate-5-Kinase against Tardive Dyskinesia

    Article • The International Journal of Neuropsychopharmacology, December 2014, Oxford University Press (OUP)

    Prof Nikolay A. Bokhan, Prof. dr. Anton J Loonen, Svetlana A Ivanova

  178. Proteins of the Akt1/GSK-3β signaling pathway in peripheral blood mononuclear cells of patients with affective disorders

    Article • Neurochemical Journal, July 2014, Pleiades Publishing Ltd

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  179. Dehydroepiandrosterone sulphate as a putative protective factor against tardive dyskinesia

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, April 2014, Elsevier

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  180. Glutamate Concentration in the Serum of Patients with Schizophrenia

    Article • Procedia Chemistry, January 2014, Elsevier

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  181. Glucose-6-phosphate dehydrogenase and catalase activities in erythrocytes of schizophrenic patients under pharmacotherapy with traditional antipsychotics

    Article • Neurochemical Journal, January 2014, Pleiades Publishing Ltd

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  182. Effects of Neuroprotector Cortexin on the Dynamics of Neuroendocrine System Parameters in Patients with Organic Emotionally Labile (Asthenic) Disorders

    Article • Bulletin of Experimental Biology and Medicine, May 2013, Springer Science + Business Media

    Svetlana A Ivanova

  183. New insights into the mechanism of drug-induced dyskinesia

    Article • CNS Spectrums, December 2012, Cambridge University Press

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  184. Conformational Stability of Leukocyte Lactate Dehydrogenase in Healthy Men of Different Age

    Article • Bulletin of Experimental Biology and Medicine, November 2012, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  185. Neurosteroids Dehydroepiandrosterone and Its Sulfate in Individuals with Personality Disorders Convicted of Serious Violent Crimes

    Article • Bulletin of Experimental Biology and Medicine, November 2012, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  186. Effects of dehydroepiandrosterone sulfate on induced apoptosis of lymphocytes in healthy persons

    Article • Human Physiology, September 2012, Pleiades Publishing Ltd

    Svetlana A Ivanova

  187. Study of the indices of antioxidant defense in mental maladaptation

    Article • Human Physiology, September 2012, Pleiades Publishing Ltd

    Svetlana A Ivanova

  188. No involvement of the adenosine A2A receptor in tardive dyskinesia in Russian psychiatric inpatients from Siberia

    Article • Human Psychopharmacology Clinical and Experimental, May 2012, Wiley

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  189. NMDA receptor genotypes associated with the vulnerability to develop dyskinesia

    Article • Translational Psychiatry, January 2012, Springer Science + Business Media

    Prof. dr. Anton J Loonen, Svetlana A Ivanova

  190. The correlation between schizophrenia duration and the serum concentration of dehydroepiandrosterone sulfate

    Article • Neurochemical Journal, December 2011, Pleiades Publishing Ltd

    Svetlana A Ivanova

  191. The state of the antioxidant system during therapy of patients with multiple sclerosis

    Article • Biochemistry (Moscow) Supplement Series B Biomedical Chemistry, March 2011, Pleiades Publishing Ltd

    Svetlana A Ivanova

  192. Spontaneous and In Vitro Induced Apoptosis of Lymphocytes and Neutrophils in Patients with Alcohol Dependence

    Article • Bulletin of Experimental Biology and Medicine, July 2010, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  193. Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia

    Article • Human Psychopharmacology Clinical and Experimental, January 2010, Wiley

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  194. PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3

    Article • Psychopharmacology, July 2009, Springer Science + Business Media

    Undine Lang, Svetlana A Ivanova

  195. Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, April 2009, Elsevier

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  196. P.3.c.044 Tardive dyskinesia and polymorphism of dopamine D3, serotonin 2A and 2C receptors in Russian psychiatric inpatients

    Article • European Neuropsychopharmacology, August 2008, Elsevier

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  197. P.3.d.010 Catabolic-anabolic balance and leucocytes's apoptosis in patients with schizophrenia

    Article • European Neuropsychopharmacology, August 2008, Elsevier

    Svetlana A Ivanova

  198. P.2.b.011 Antidepressant therapy and apoptosis of immnocompetent cells in patients with depressive disorders

    Article • European Neuropsychopharmacology, October 2007, Elsevier

    Svetlana A Ivanova

  199. P.3.c.017 Influence of atypical neuroleptic quetiapine on the serum dehydroepiandrosterone/ cortisol ratio in schizophrenia

    Article • European Neuropsychopharmacology, October 2007, Elsevier

    Svetlana A Ivanova

  200. Signs of apoptosis of immunocompetent cells in patients with depression

    Article • Neuroscience and Behavioral Physiology, June 2007, Springer Science + Business Media

    Svetlana A Ivanova

  201. P.6.063 Clinical and biological effectiveness of anar therapy in opiate addicts

    Article • European Neuropsychopharmacology, January 2005, Elsevier

    Professor Tamara P. Vetlugina, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  202. P.1.045 Psychotropic drugs and homeostatic systems: Mechanism of psychoneuroimmunomodulation

    Article • European Neuropsychopharmacology, January 2005, Elsevier

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  203. P.2.016 Influence of atypical neuroleptic on cell apoptosis in patients with schizophrenia in the course of the therapy

    Article • European Neuropsychopharmacology, January 2005, Elsevier

    Dr Olga Lobacheva, Svetlana A Ivanova

  204. P.1.107 Influence of pharmacotherapy on fas-receptorsand spontaneous apoptosis of lymphocytes in patients with depressive disorders

    Article • European Neuropsychopharmacology, October 2004, Elsevier

    Professor Tamara P. Vetlugina, Svetlana A Ivanova

  205. Immunity system in alcoholism

    Article • Alcoholism Clinical and Experimental Research, August 2004, Wiley

    Professor Tamara P. Vetlugina, Prof Nikolay A. Bokhan, Svetlana A Ivanova

  206. Article • Bulletin of Experimental Biology and Medicine, January 2003, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova

  207. Article • Bulletin of Experimental Biology and Medicine, January 2003, Springer Science + Business Media

    Prof Nikolay A. Bokhan, Svetlana A Ivanova